BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//WA Innovation Calendar - ECPv6.18.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://wainnovationcalendar.com.au
X-WR-CALDESC:Events for WA Innovation Calendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Perth
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:AWST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240208T070000
DTEND;TZID=Australia/Perth:20240208T073000
DTSTAMP:20260407T062904Z
CREATED:20240126T051635Z
LAST-MODIFIED:20260407T062904Z
UID:10001855-1707375600-1707377400@wainnovationcalendar.com.au
SUMMARY:ARIIAxMDPP – Incubating new ideas for technology to transform aged care
DESCRIPTION:Information session: Learn more about the ARIIAxMDPP Ideas Incubator program with Q&A \n\n\n\n\n\n\n\nThe ARIIA x MDPP Ideas Incubator Program aims to support early-stage product or technology innovation ideas to be developed for Aged Care. \nARIIA and the Medical Device Partnering Program (MDPP) are excited to collaborate on this initiative. The MDPP has been supporting the development of medical devices since 2008 under the leadership of Professor Karen Reynolds\, who is also the Director of ARIIA’s Aged Care Partnering Program (ACPP). \nSuccessful applicants will be provided with up to 250 hours of professional technical expertise by Flinders University engineers\, which may include proof of concept research\, prototyping or product technical validation. Further\, successful applicants will be provided with a market opportunity report as a result of an additional 30 hours (maximum) of professional expertise as well as connections to / introductions with aged care providers\, end-users\, potential manufacturers\, and commercial partners (where appropriate). \nTo find out more\, we invite you to attend one of the following Q&A sessions: \n• Wednesday\, 6th December at 12noon Adelaide time \n• Monday\, 22nd January at 2.30pm Adelaide time \n• Thursday\, 8th February at 9.30am Adelaide time \n• Friday\, 23rd February at 10am Adelaide time \n• Tuesday\, 5th March at 3pm Adelaide time \n• Friday\, 22nd March at 12.30pm Adelaide time \n• Wednesday\, 10th April at 1pm Adelaide time \n• Monday\, 29th April at 12noon Adelaide time \n• Tuesday\, 14th May at 3pm Adelaide time \nThis is an Online Event. A Microsoft Teams link will be sent by email to registered attendees prior to the event. \nif you have any questions you’d like answered in the session\, please email them to acpp@ariia.org.au
URL:https://wainnovationcalendar.com.au/event/ariiaxmdpp-incubating-new-ideas-for-technology-to-transform-aged-care/
LOCATION:online\, Australia
CATEGORIES:Information Session / Launch
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240208T170000
DTEND;TZID=Australia/Perth:20240208T190000
DTSTAMP:20260407T062904Z
CREATED:20240111T022531Z
LAST-MODIFIED:20260407T062904Z
UID:10001792-1707411600-1707418800@wainnovationcalendar.com.au
SUMMARY:Spotlight on commercialising medtech; a US and Australian perspective
DESCRIPTION:Do you want to know what it takes to take novel medtech to market? \n\n\n\n\n\n\n\n\nThe WA Life Sciences Innovation Hub invites you to our next WA MTP Sector Spotlight Series event\, a fireside chat focused on medtech commercialisation with Jill Anderson (OncoRes Medical Non-Executive Director) sharing her experiences in the US and Dr Kath Giles (OncoRes Medical CEO/MD; Brandon Capital Venture Partner) providing the Australian perspective. \nAbout our topic \nDuring this event we will gain insights into medtech commercialisation from two leaders\, a successful founder from the US and the CEO of fast-growing WA start-up\, OncoRes Medical. \nOncoRes Medical’s Non-Executive Director Ms Jill Anderson brings a wealth of knowledge and expertise about the American medtech landscape. Jill has extensive experience as the Co-Founder\, President and CEO of Cianna Medical (acquired in 2018 for $200M)\, as well as Director of OncoRes\, Minerva Surgical and Merit Medical Systems. \nOncoRes Medical’s CEO and MD Dr Kath Giles will offer insights from her experience as a business leader\, clinician\, innovator and investor\, and her perspective on what it takes to commercialise medtech in WA. \nThrough this fireside chat led by WA Life Sciences Innovation Hub’s Dr Tracey Wilkinson\, we aim to foster a vibrant conversation about what it takes to successfully bring a novel medical technology to market to benefit patients. Whether you are an aspiring entrepreneur\, industry professional\, investor\, or simply interested in the field\, this event promises to provide valuable perspectives on the global medtech industry. \nAbout this event \nOur monthly event series is an opportunity for representatives from across the MTP sector to connect\, collaborate and learn about upcoming opportunities\, and hear the stories and successes of WA organisations developing health and medical innovations. Join us for networking and conversation over light refreshments afterwards. \nWe’re pleased to be delivering this event in partnership with The Centre for Entrepreneurial Research and Innovation (CERI)\, a social enterprise supporting the next generation of WA’s entrepreneurs. Their programs have been designed to educate and empower early-stage entrepreneurs\, PhD students and visionaries within the WA community. \nAbout OncoRes Medical \nFounded in 2016\, OncoRes Medical is a Perth-based medical device company dedicated to eliminating the burdens associated with repeat operations following breast-conserving surgery (BCS). The company is developing a hand-held\, real-time intraoperative imaging device to improve the detection of residual tumour in the surgical cavity\, providing surgeons with the confidence that no residual cancer remains in the breast. This innovative solution is based on technology developed in collaboration with the University of Western Australia and Western Australian Department of Health. Learn more at www.oncoresmedical.com. \nAbout our speakers \nDr Katharine Giles – CEO/Managing Director \nDr Kath Giles has been CEO/Managing Director of OncoRes since 2017. Kath has experience on both sides of the funding process\, having worked as an Investment Manager at Stone Ridge Ventures and then joining Brandon Capital Partners in 2012 as a Venture Partner. Kath has start-up experience in medical apps\, diagnostics and fitness devices and continues to practice as a medical doctor working within the surgical field. Before entering the commercial world\, Kath spent time working in clinical medicine gaining a range of experience across medical and surgical specialities and critical care. Kath combines her investment experience and clinical knowledge with a keen business insight. She is a Director of Respirion Pharmaceuticals\, Non-Executive Director of Sonic Healthcare and a founding Committee Member of the Australian Society for Medical Entrepreneurship & Innovation (ASME). \nShe is also a Graduate of the Australian Institute of Company Directors. \nJill Anderson – Non-Executive Director \nMs Jill Anderson is dedicated to enhancing the lives of consumers through medical technology. Jill is a business strategist and commercial expert with extensive industry experience in medical devices and healthcare services. She was Co-Founder\, President and Chief Executive Officer of Cianna Medical from 2008 until its acquisition in 2018. Prior to that\, she was Vice President of BioLucent from 2001 to 2003\, becoming President in 2003 until its acquisition in 2007. \nPrior to entering the medical device field\, Jill held executive leadership positions in health care services\, focused on developing patient-centric\, comprehensive cancer centers in partnership with large\, teaching hospital environments. In addition to her service on the OncoRes Board\, Jill also serves on the Board of Minerva Surgical\, a uterine health medtech company focusing on minimally invasive intrauterine treatments\, as well as on the Board of Merit Medical Systems\, Inc. (NASDAQ: MMSI)\, a leading manufacturer and marketer of proprietary disposable medical devices used in interventional\, diagnostic and therapeutic procedures\, particularly in cardiology\, radiology\, oncology\, critical care and endoscopy.
URL:https://wainnovationcalendar.com.au/event/spotlight-on-commercialising-medtech-a-us-and-australian-perspective/
LOCATION:The Centre for Entrepreneurial Research and Innovation (CERI)\, Level 1\, 22 Stirling Highway Nedlands\, WA 6009\, 6009\, Australia
CATEGORIES:Seminar / Panel Discussion / Conversation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240209T080000
DTEND;TZID=Australia/Perth:20240209T090000
DTSTAMP:20260409T020904Z
CREATED:20240123T043006Z
LAST-MODIFIED:20260409T020904Z
UID:10001827-1707465600-1707469200@wainnovationcalendar.com.au
SUMMARY:DEADLINE: IPrep Biodesign Course EOIs
DESCRIPTION:Completion of this form will provide access to application details of the recruited PhD student cohort and an invitation to the 1st stage induction\, where each student will present a pitch. There is no obligation to continue with the program if applicants are not deemed a suitable fit for your project. \niPREP Biodesign will handle your personal information in accordance with university policies and the Australian Privacy Principles. iPREP Biodesign collects your personal information\, including your name\, contact details and company details for the purposes of the program and may be used to guide future iterations of the program. \nWe provide a cost-effective solution to tackle your organisation’s R&D challenges\n\n\nBenefits:  \n\n\nA multidisciplinary team of two or three PhD students \n\n\nCost effective\, potentially eligible for R&D tax incentive & subsidies \n\n\n100% ownership of intellectual property \n\n\nSelect students appropriate to your project and skill-gap \n\n\n‘Test-drive’ students prior to potential employment \n\n\nA flexible participation mode (virtual\, in-person\, combination) \n\n\n\n\n\n Our support:  \n\n\nWe source appropriate skill-sets and offer guidance in selecting the best suited researchers to your project  \n\n\nWe provide students with weekly support and specialised training to assist with the scoping of your project\, meeting deliverables and translation of research abilities into tangible outcomes  \n\n\nWe focus on value creation by actively looking for synergistic opportunities and connections to like-minded industry partners\, educational institutions and research centres  \n\n\n\n\n\n\n\n\n\n\n\nProjects are defined by the industry partner and can span over a 7 week or 3 month period. Projects may include new research\, proof-of-concept activities or tasks progressing commercial outputs.Students should not undertake day-to-day commercial activities\, but focus on a short-term research project related to their area of expertise. All Intellectual Property created during the project is retained by the industry partner and creation of non-disclosure agreements is supported.
URL:https://wainnovationcalendar.com.au/event/deadline-iprep-biodesign-course-eois/
LOCATION:Apply online\, Australia
CATEGORIES:DEADLINE: Accelerator / Incubator
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240215T133000
DTEND;TZID=Australia/Perth:20240215T170000
DTSTAMP:20260407T062904Z
CREATED:20240121T040308Z
LAST-MODIFIED:20260407T062904Z
UID:10001824-1708003800-1708016400@wainnovationcalendar.com.au
SUMMARY:The Digital Health Evolution and Surviving Due Diligence with Lisa Suennen
DESCRIPTION:Join ANDHealth for the fourth instalment in the WA Connected Health Commercialisation Initiative Expert Workshop Series!\n  \nWe are joined by special international guest Lisa Suennen\, CEO\, Venture Valkyrie\, based in California\, who will deliver a comprehensive workshop on surviving due diligence in digital health. \nFirstly\, Lisa will step us through the evolution of digital health over the years and what the digital health market currently looks like in 2024\, along with the challenges of growth within market. \nFollowed by a world-class presentation on due diligence in digital health for innovators\, including the crucial things to consider when evaluating risk and opportunity for your product\, and the steps you must take to ensure effective due diligence. \n  \nKey learning outcomes from this workshop include: \n\nWhat digital health evolution looks like in 2024\nUnderstanding the challenges of growth\, particularly in the US market\nDefining due diligence and key considerations\nDue diligence: a 12 step program\n\n  \nWACHCI Expert Series Workshop 4 – The Evolution of Digital Health and Surviving Due Diligence with Lisa Suennen\nDate: Thursday 15 February 2024\nTime: Workshop: 1:30 pm – 5:00 pm | Networking Drinks: 5:00pm-6:30pm (same location)\nLocation: Wrays – Level 7\, 863 Hay St\, Perth WA 6000 \nLisa’s Bio  \nLisa leads Venture Valkyrie\, LLC\, her personal advisory firm\, as well as her other various advising\, writing and speaking activities. \nAs of January 2024\, Lisa leads American Heart Association Ventures as Managing Partner. AHA Ventures has multiple programs for double bottom-line impact investing across the healthcare continuum. The current programs include Cardeation and two Social Impact Funds\, with more to come. \nLisa is also on faculty at the UC Berkeley Haas School of Business\, where she has taught an annual semester-long class on venture capital and innovation for the last 14 years. \nLisa is an National Advisor to professional services firm Manatt\, Phelps & Phillips and on the advisory boards of several young companies and a few venture funds\, and has served on numerous private company\, public company and not-for-profit boards of directors throughout my career. \nShe currently chairs the Scientific Advisory Board of the NASA Translational Research Institute and the International Investment Advisory Committee (IIAC) of ANDHealth Limited\, a digital health investment initiative funded by the Australian and Victorian governments\, amongst several other emerging healthcare companies. \nLisa is also founder of CSweetener\, a not-for-profit organization that matches rising women leaders in healthcare with luminaries that guide their careers during year-long virtual mentorships. \nConditions:  \n\nWACHCI workshops are free to WA Digital and Digitally Enabled Medical Technology Companies thanks to the support of the WA Life Sciences Innovation Hub.\nAll participating companies will be required to participate in post-workshop surveys as a condition of registration. Companies which do not complete post-workshop surveys may be required to pay a registration fee for any future workshops.\nNumbers are strictly limited with only 30 seats available at each workshop.\nANDHealth reserves the right to allocate limited availability to maximise the number of companies that will benefit from the program.\n\n  \nNOTE:\nIf you are interested in participating this workshop but have not attended past ANDHealth events or programs within the last three months\, you are required to fill out the following form: https://airtable.com/appyTjaf7…
URL:https://wainnovationcalendar.com.au/event/the-digital-health-evolution-and-surviving-due-diligence-with-lisa-suennen/
LOCATION:Wrays\, Australia
CATEGORIES:Seminar / Panel Discussion / Conversation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240218T080000
DTEND;TZID=Australia/Perth:20240218T090000
DTSTAMP:20260409T020904Z
CREATED:20240123T021424Z
LAST-MODIFIED:20260409T020904Z
UID:10001825-1708243200-1708246800@wainnovationcalendar.com.au
SUMMARY:DEADLINE: CSIRO Digital Health & Medical Tech Program
DESCRIPTION:Limited spots available for CSIROS upcoming digital health and medical technology program!\n\n\n\n\n\nImportant notes:\n\nPlease ensure you can commit 2-3 hours per week and can attend the half-day workshop on Thursday 14 March 2024.\nPlease ensure you meet the essential criteria and review our FAQs before submitting this application form. Essential criteria includes:\n\nAn Australian registered and operating business with an ABN and ACN/ICN.\nPlease note: Sole traders and Partnerships are not eligible to apply for the program. Businesses need to be registered and have their primary place of business within Australia (Australian subsidiary companies of foreign entities are not eligible).\nA business classified as small to medium (less than 200 employees).\nA business with a R&D idea to work on throughout the program\, which is related to Digital Health and/or Medical Technology.\n\n\nEnter details for the person from your company who will be participating in the webinars and submitting documents (please ensure you provide the correct contact details) and have permission to attend (if relevant).\nIf we have more applications than places available\, we may include region or sub-sector as well as suitability to make our final list. This helps to provide diversity in the program cohort.\nApplications for this program will close on Sunday 18 February 2024. We will notify you of the outcome within two weeks of the closing date.\n\nPlease complete this form if you would like to be considered for the Digital Health and Medical Technology program. There is currently no fee for participating in Innovate to Grow.
URL:https://wainnovationcalendar.com.au/event/deadline-csiro-digital-health-medical-tech-program/
LOCATION:Apply online\, Australia
CATEGORIES:DEADLINE: Accelerator / Incubator
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240222T080000
DTEND;TZID=Australia/Perth:20240222T170000
DTSTAMP:20260407T070609Z
CREATED:20240121T030127Z
LAST-MODIFIED:20260407T070609Z
UID:10001822-1708588800-1708621200@wainnovationcalendar.com.au
SUMMARY:WA BioInnovation Symposium
DESCRIPTION:The fifth Western Australia BioInnovation Symposium is a premier event in Western Australia that showcases the latest and greatest in life sciences innovations. The symposium serves as a convergence point for innovators\, industry partners\, and investors\, offering a unique opportunity to explore partnering opportunities in life science sectors. \nThrough a series of presentations and networking events\, innovators will have the opportunity to share their groundbreaking work while industry partners and investors can share what they’re looking for and how to best work with them. The symposium will also showcase some of WA’s formidable platform capabilities\, emphasising the region’s prowess in driving cutting-edge advancements in the life science sector. \n  \nEvent Page HERE
URL:https://wainnovationcalendar.com.au/event/wa-bioinnovation-symposium/2024-02-22/
LOCATION:The Westin\, 4480 Hay Street\, Perth\, Western Australia\, 6000\, Australia
CATEGORIES:Conference / Summit / Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240222T180000
DTEND;TZID=Australia/Perth:20240222T200000
DTSTAMP:20260407T065247Z
CREATED:20240131T064754Z
LAST-MODIFIED:20260407T065247Z
UID:10001863-1708624800-1708632000@wainnovationcalendar.com.au
SUMMARY:Trailblazing Women with Joanna Morris of Matilda
DESCRIPTION:Joanna Morris\, is the co-founder and CEO of Matilda\, an evidence based digital platform which aims to provide affordable and accessible holistic care for people with endometriosis. \nMatilda does this through symptom and lifestyle tracking\, evidence based learning resources\, access to a supportive community of endo-warriors and expert clinicians and live and on demand classes delivered by holistic care practitioners. \nJoanna sits down with CEO of We Are Emersyn\, Megan Del Borrello\, to discuss how she and her business partner\, Dr Kevin Wernli (PhD)\, built Matilda and why she is so passionate about getting Matilda into the hands of people who need it\, empowering them to live a better life. \nAfterwards we’ll open up the floor for questions. \nA dedicated Continence and Women’s Health Physiotherapist\, specialising in the assessment and treatment of endometriosis\, pelvic pain and sexual dysfunction\, Jo graduated from Curtin University in 2012 with an Bachelor of Science (Physiotherapy) and after quickly realising her love for women’s health\, went on to further study a Masters of Physiotherapy (Continence and Women’s Health) degree\, graduating in 2018. \nIn her spare time\, Jo loves to spend time with her young family and golden retriever\, going for walks at the beach or camping down south. \nJoin us for an evening of real conversations and connections with delicious food and refreshing drinks. \n🗓️ Date & Time\nThursday 22nd February 6pm-8pm \n🕥Timings\n6:00pm to 6:25pm: Registration\, Networking & Refreshments\n6:30pm to 7:30pm – Event Start\, Talk and Q & A\n7:30pm to 8:00pm – Networking & Event Close \n📍 Location\nThe Platform | 3/256 Adelaide Terrace\, Perth \n🎟️Pricing\nGeneral Admission Tickets: $22 + BF\nBook here: https://events.humanitix.com/trailblazing-women-with-joanna-morris-from-matilda \n🌐 Who Should Attend\nThis event is open to everyone including leaders and supporters with a shared perspective. \n🙏Supported by\nThis event is the first of 4 in our Female Founder Insight Series and is made possible by Meshpoints\, supported by Spacecubed and Lotterywest\, which exists to build a stronger culture of entrepreneurship and innovation in Western Australia.
URL:https://wainnovationcalendar.com.au/event/trailblazing-women-with-joanna-morris-of-matilda/
LOCATION:The Platform\, 256 Adelaide Terrace #3 Perth\, WA 6000 Australia\, Perth\, Australia\, 6000\, Australia
CATEGORIES:Networking / Group Meetup
ATTACH;FMTTYPE=image/png:https://wainnovationcalendar.com.au/wp-content/uploads/2024/01/LinkedIn-Event-Trailblazing-Women.png
ORGANIZER;CN="We Are Emersyn":MAILTO:megan@weareemersyn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240223T080000
DTEND;TZID=Australia/Perth:20240223T130000
DTSTAMP:20260407T070609Z
CREATED:20240121T030127Z
LAST-MODIFIED:20260407T070609Z
UID:10001823-1708675200-1708693200@wainnovationcalendar.com.au
SUMMARY:WA BioInnovation Symposium
DESCRIPTION:The fifth Western Australia BioInnovation Symposium is a premier event in Western Australia that showcases the latest and greatest in life sciences innovations. The symposium serves as a convergence point for innovators\, industry partners\, and investors\, offering a unique opportunity to explore partnering opportunities in life science sectors. \nThrough a series of presentations and networking events\, innovators will have the opportunity to share their groundbreaking work while industry partners and investors can share what they’re looking for and how to best work with them. The symposium will also showcase some of WA’s formidable platform capabilities\, emphasising the region’s prowess in driving cutting-edge advancements in the life science sector. \n  \nEvent Page HERE
URL:https://wainnovationcalendar.com.au/event/wa-bioinnovation-symposium/2024-02-23/
LOCATION:The Westin\, 4480 Hay Street\, Perth\, Western Australia\, 6000\, Australia
CATEGORIES:Conference / Summit / Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240229T160000
DTEND;TZID=Australia/Perth:20240229T180000
DTSTAMP:20260407T055653Z
CREATED:20240214T050404Z
LAST-MODIFIED:20260407T055653Z
UID:10001906-1709222400-1709229600@wainnovationcalendar.com.au
SUMMARY:“AI & the Evolution of Vaccine Development” with Dr Wayne C. Koff\, PhD
DESCRIPTION:Join us for a unique opportunity to delve into the future of biomedical research and the transformative role of AI in vaccine. \n\n\n\n\n\n\n\n\n\n🔍 About the Event: Join us for an illuminating talk on the cutting edge of scientific exploration as Dr. Wayne C. Koff\, a renowned expert in human immunology\, vaccine development\, and artificial intelligence\, takes centre stage in Perth\, Western Australia\, direct from the USA. \nThis event offers a unique opportunity to delve into the future of biomedical research and the transformative role of AI in vaccine development. \n🌟 Speaker’s Profile: Dr. Wayne C. Koff brings a wealth of experience to the stage as the Managing Partner of NEXT FRONTIER ADVISORS. Formerly the President and CEO of the Human Immunome Project\, Dr. Koff has been at the forefront of decoding the human immune system. His accolades include being named one of the “100 Global Thinkers” by Foreign Policy\, alongside global leaders such as Barack and Michelle Obama and Bill and Melinda Gates. \nDr. Koff\, is an Adjunct Professor at the Harvard Chan School of Public Health and the former Chief Scientific Officer of the International AIDS Vaccine Initiative (IAVI)\, where he conducted groundbreaking clinical trials of experimental AIDS vaccines globally. His dedication to advancing vaccine research has earned him recognition as a thought leader and a place among the most influential global thinkers. \nAgenda \n\n3.30pm Registrations\n4.00pm Welcome: Alex Jenkins\, Director\, WA Data Science Innovation Hub\n4.05pm Introduction: Assoc. Prof. Parwinder Kaur PhD\, DNA Zoo\n4.10pm Keynote: ‘AI & the Evolution of Vaccine Development’\, Dr Wayne C. Koff\, PhD\n4.40pm Panel Discussion + Audience Q&A ; Facilitated by Assoc. Prof. Parwinder Kaur. Panelists: Dr Wayne C. Koff; Prof. Peter Klinken\, Chief Scientist of WA; Alex Jenkins.\n5.00pm Networking drinks\n6.00pm Event Close\n\n🎟️ Don’t Miss Your Chance: Secure your spot to gain insights into the future of vaccine development\, AI\, and global health. \nNetwork with like-minded professionals\, researchers\, and enthusiasts as we explore the transformative potential of science in shaping a healthier world. \nThis event is proudly brought to you by the WA Data Science Innovation Hub\, with Event Supporter\, DNA Zoo Australia
URL:https://wainnovationcalendar.com.au/event/ai-the-evolution-of-vaccine-development-with-dr-wayne-c-koff-phd/
LOCATION:Curtin University\, Australia
CATEGORIES:Information Session / Launch
END:VEVENT
END:VCALENDAR